| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 189.934 | 199.145 | 191.813 | 197.846 | 197.605 | 214.177 | 209.425 | 216.794 | 210.607 | 209.243 |
| Total Income - EUR | 191.727 | 199.434 | 192.188 | 198.194 | 197.954 | 215.589 | 209.803 | 218.242 | 212.225 | 209.346 |
| Total Expenses - EUR | 183.153 | 189.732 | 184.595 | 188.636 | 187.384 | 200.752 | 198.730 | 209.943 | 211.399 | 207.229 |
| Gross Profit/Loss - EUR | 8.573 | 9.702 | 7.593 | 9.558 | 10.570 | 14.837 | 11.074 | 8.300 | 826 | 2.117 |
| Net Profit/Loss - EUR | 6.973 | 7.920 | 5.766 | 7.587 | 8.591 | 13.340 | 9.118 | 6.357 | -1.180 | -2.927 |
| Employees | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Oxalys Tehnofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.973 | 17.698 | 17.891 | 17.562 | 17.222 | 16.783 | 15.410 | 14.454 | 13.482 | 12.558 |
| Current Assets | 46.622 | 39.837 | 40.166 | 40.418 | 39.429 | 43.728 | 45.616 | 45.748 | 43.342 | 40.070 |
| Inventories | 30.145 | 28.788 | 29.339 | 27.393 | 27.648 | 33.458 | 31.966 | 32.420 | 28.562 | 28.757 |
| Receivables | 9.575 | 2.256 | 7.504 | 9.753 | 8.289 | 7.910 | 8.476 | 8.727 | 10.675 | 6.011 |
| Cash | 6.902 | 8.793 | 3.323 | 3.272 | 3.492 | 2.360 | 5.174 | 4.601 | 4.106 | 5.301 |
| Shareholders Funds | 12.313 | 16.357 | 20.003 | 26.770 | 33.735 | 40.451 | 40.054 | 40.184 | 31.631 | 22.628 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 53.282 | 41.178 | 38.054 | 31.210 | 22.917 | 20.061 | 20.972 | 20.018 | 25.193 | 30.000 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Oxalys Tehnofarm S.r.l.